These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17297747)

  • 1. Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
    Weigl DM; Arbel N
    Dev Med Child Neurol; 2007 Feb; 49(2):159-60. PubMed ID: 17297747
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.
    Linder-Lucht M; Kirschner J; Herrmann J; Geth K; Korinthenberg R; Berweck S; Heinen F; Mall V
    Dev Med Child Neurol; 2006 Apr; 48(4):319-20. PubMed ID: 16542523
    [No Abstract]   [Full Text] [Related]  

  • 3. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
    Gough M
    Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Botulinum toxin treatment of spastic cerebral palsy].
    Hansen LK; Pedersen NR; Westphall IT; Pedersen LT; Jensen H; Villads A
    Ugeskr Laeger; 2004 Aug; 166(34):2888-90. PubMed ID: 15449526
    [No Abstract]   [Full Text] [Related]  

  • 6. The expanding role of botulinum toxin type A injections in the management of children with cerebral palsy.
    Carr LJ
    Dev Med Child Neurol; 2009 Sep; 51(9):687-8. PubMed ID: 19709139
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of botulinum toxin type A in children with cerebral palsy.
    Nolan KW; Cole LL; Liptak GS
    Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinum toxin and cerebral palsy: time for reflection?
    Kerr Graham H; Rodda JM
    Dev Med Child Neurol; 2006 May; 48(5):399. PubMed ID: 16608552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of drooling with botulinum toxin type A in cerebral palsy].
    Duarte CS; Alves TR; Azeredo PM; Almeida SI
    Rev Neurol; 2009 Dec 1-15; 49(11):610. PubMed ID: 19921629
    [No Abstract]   [Full Text] [Related]  

  • 10. [Botulinum toxin in infantile cerebral palsy].
    Póo P; Galván-Manso M; Casartelli MJ; López-Casas J; Gassió-Subirats RM; Blanco C; Terricabras-Carol L
    Rev Neurol; 2008; 47 Suppl 1():S21-4. PubMed ID: 18767013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence on ''Outcome measures used in studies of botulinum toxin in childhood cerebral palsy: a systematic review''.
    Bares M; Minks E; Husárová I; Ferencová K
    J Child Neurol; 2010 Jun; 25(6):793-4; author reply 794. PubMed ID: 20508237
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children.
    Kumar R; Sneade C; Littler K
    Dev Med Child Neurol; 2009 Oct; 51(10):838-9. PubMed ID: 19747281
    [No Abstract]   [Full Text] [Related]  

  • 15. Parent evaluation of spasticity treatment in cerebral palsy using botulinum toxin type A.
    Symons FJ; Rivard PF; Nugent AC; Tervo RC
    Arch Phys Med Rehabil; 2006 Dec; 87(12):1658-60. PubMed ID: 17141650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.
    Scheinberg A; O'Flaherty S; Waugh MC; Baxter A; Gurd K
    J Paediatr Child Health; 2008; 44(7-8):468-9; author reply 469. PubMed ID: 18638338
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type a injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy.
    Kim H; Lee Y; Weiner D; Kaye R; Cahill AM; Yudkoff M
    Arch Phys Med Rehabil; 2006 Jan; 87(1):141-4. PubMed ID: 16401453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are current practices in the treatment of children with cerebral palsy research-based?
    Autti-Rämo I; Anttila H; Mäkelä M
    Dev Med Child Neurol; 2007 Feb; 49(2):155-6. PubMed ID: 17254006
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of childhood spasticity secondary to cerebral palsy using Botox.
    Gill C; Covington C; Padaliya B; Newman W; Pomeroy T; Charles PD
    Tenn Med; 2003 Nov; 96(11):511-3. PubMed ID: 14635360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.